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ABSTRACT
Objectives: Demand for new antibiotic is rising up due to continuous resistance risk against conventional antibiotic. 
This attempt was taken to find out a novel antimicrobial metabolite.
Methods: Chili field antagonistic actinomycetes Streptomyces albolongus was isolated and tested for optimum antimi-
crobial metabolite production. Primary screening was done by selective media and antibiotic assay was done by agar 
cup plate method. Fermented product was recovered by separating funnel using suitable solvent.
Results: Maximum antimicrobial metabolite production was found at temperature 35°C and pH 9.0 and on 6th day of 
incubation. The medium consisting of corn steep liquor (0.2%), glucose (1.0%), NaCl (0.5%), K2HPO4 (0.1%) was screened 
out as suitable medium for maximum antimicrobial production. Sucrose was found as the best carbon source among 
four sources. The antimicrobial metabolite was found to be stable at pH and temperature up to 11.0 and 100°C respec-
tively. The active agent was best extracted with chloroform. The antimicrobial spectrum of the metabolite was wide 
and shows activity against Shigella dysenteriae (AE14612), Shigella sonnei (CRL, ICDDR, B), Salmonella typhi (AE14296), 
Vibrio cholerae (AE14748), Pseudomonas aeruginosa (CRL, ICDDR, B), Bacillus cereus (BTCC19), Staphylococcus aureus 
(ATCC6538), Bacillus subtilis (BTTC17) and Bacillus megaterium (BTTC18).
Conclusions: The findings of antibacterial activity of S. albolongus against several species of human pathogens includ-
ing both Gram-positive and Gram-negative bacteria indicated that our produced material might be an alternative anti-
microbial substance to control human diseases. J Microbiol Infect Dis 2013; 3(2): 75-82
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Uygun çevre koşullarında Streptomyces albolongus ile oluşan biyoaktif metabolit üretimi
ÖZET
Amaç: Günümüzde konvansiyonel antibiyotiklere karşı artan direnç riski nedeniyle yeni antibiyotiklere gereksinim vardır. 
Bu çalışmada yeni bir antimikrobiyal bileşiğin elde edilmesi denenmektedir.
Yöntemler: Bir aktinomiçes türü olan Streptomyces albolongus izole edilerek optimal antimikrobiyal metabolit üretimi 
açısından değerlendirildi. İlk tarama seçici besiyeri ve antibiyotik assay ise “agar cup-plate” metodu ile yapıldı. Fermente 
ürün uygun bir çözücü yardımıyla ayırma hunisi ile elde edildi. 
Bulgular: Maksimum antimikrobiyal metabolit üretimi 35°C sıcaklık ve pH 9.0’da inkübasyonun altıncı gününde göz-
lendi. Denen besiyerleri arasında mısır ıslatma suyu (%0,2), glukoz (%1), NaCl (%0,5) ve K2HPO4 (%0,1) içeren besiyeri 
maksimum metabolit üretimi için en uygun besiyeri idi. Sukroz, diğer dört kaynak arasında en iyi karbon kaynağı idi. 
Bulunan antimikrobiyal metabolit sırasıyla pH 11,0 ve 100°C sıcaklığa kadar dayanıklı idi. Aktif ajan en iyi kloroform ile 
ekstrakte edildi. Bulunan metabolitin antimikrobiyal spektrumu geniş idi ve Shigella dysenteriae (AE 14612), Shigella 
sonnei (CRL, ICDDR, B), Salmonella typhi (AE14296), Vibrio cholerae (AE14748), Pseudomonas aeruginosa (CRL, ICDDR, B), 
Bacillus cereus (BTCC19), Staphylococcus aureus (ATCC6538), Bacillus subtilis (BTTC17) ve Bacillus megaterium (BTTC18) 
gibi bakterileri kapsıyordu.
Sonuç: Araştırmada S. albolongus’un Gram-positif ve Gram-negatif bakterileri içeren değişik insan patojenlerine karşı 
etkisi hakkında elde edilen bulgular ürettiğimiz materyalin insanlardaki hastalıkların kontrolünde alternatif antimikrobi-
yal bir madde olabileceğini göstermektedir.
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INTRODUCTION
There is great opportunity for discovering new 
groups of microorganisms with industrial and clini-
cal importance in soil.1 The top cultivable antibiotic 
producers present in soil are the actinomycetes.2 
These bacteria comprise about 10-33% of the to-
tal bacterial community present in soil.3 The genus 
Streptomyces is responsible for the synthesis of the 
majority of antimicrobial agents with clinical impor-
tance.4 On the whole, the last 55 years have seen 
the discovery of more than 12.000 antibiotics and 
actinomycetes yielded about 70% of these.5 Most of 
the bioactive compounds from actinomycetes sort 
into several major structural classes such as ami-
noglycosides (e.g. streptomycin and kanamycin), 
ansamycins (e.g. rifampin), anthracyclines (e.g. 
doxorubicin), β-lactams (e.g. cephalosporins), mac-
rolides (e.g. erythromycin) and tetracycline.6-11 Most 
of the antibiotics are extracellular-secondary me-
tabolites which are normally secreted in culture me-
dia and serve as intermediates from primary metab-
olisms as precursors for their biosynthetic process 
and they have been used as herbicides, anticancer 
agents, drugs, immunoregulators and antiparasitic 
agents.12 Despite critical need for new antibiotics to 
treat drug-resistant infections and other infectious 
diseases, very few new antibiotics are being devel-
oped.13 The nutritional sources like carbon, nitro-
gen, time, and minerals, the environmental factors 
such as temperature and pH are found to have pro-
found influence on antibiotic production by actino-
mycetes.14 Optimization of the culture conditions is 
essential to get high yields of the metabolites. Con-
sidering above-mentioned facts the present study 
was undertaken to find out and optimize the growth 
of antibiotic producing microbial isolates.
METHODS
Isolation and purification of the antibiotic 
producing microorganisms
The media used for the isolation of antibiotic pro-
ducing microorganisms were nutrient agar medium, 
oat meal agar medium and starch casein medium.15 
One gram of soil sample was mixed with 100 ml 
of sterile water in a conical flask, shaken well with 
magnetic stirrer and then allowed to stand for 30 
minutes for sedimentation. Necessary dilution (up 
to 10-5) was made with this mother solution. The 
samples (0.1 ml) were used for inoculating 15 ml 
molten medium at 45-50°C in Petri plates and the 
plates were incubated at 37°C for about 4 to 5 
days. Observation was made at 24 hours intervals 
to detect any colony surrounded by a clear zone of 
inhibition. Both the organisms (inhibiting and inhib-
ited) involved in antagonistic reaction were isolated 
aseptically and transferred to slant of the same me-
dium. The inhibiting and the inhibited colonies were 
marked as X-organisms and Y-organisms respec-
tively. The isolated organisms were purified through 
repeated plating. Streaking on nutrient agar and oat 
meal agar was done for these purposes. The puri-
fied isolates were then transferred to starch casein 
agar.
Primary screening by sensitivity spectrum 
analysis
Primary screening was made by sensitivity spec-
trum analyses test against 10 test organisms. Per-
pendicular streak plate method was used for this 
purpose.16 In the present study, to screen the an-
timicrobial activity of microbial secondary metabo-
lites 10 human standard pathogenic bacteria strains 
were used as test organisms. Among them, 6 were 
Gram negative including Shigella dysenteriae (AE 
14612), Shigella sonnei (CRL, ICDDR, B), Salmo-
nella typhi (AE 14296), Vibrio cholerae (AE 14748), 
Escherichia coli (ATCC25922), Pseudomonas aeru-
ginosa (CRL, ICDDR, B) and 4 were Gram positive 
including Bacillus cereus (BTCC 19), Staphylococ-
cus aureus (ATCC 6538), Bacillus subtilis (BTTC 
17) and Bacillus megaterium (BTTC 18). Three dif-
ferent media namely nutrient agar (NA) medium, 
starch casein agar (SCA) medium and Czapek Dox 
Agar (CDA) medium were used for primary screen-
ing. In each case, the melted medium was poured 
into Petri plate and allowed to solidify. The isolate 
was streaked across the surface of the agar me-
dium at the middle position of the plate and incu-
bated at 37°C for growth. After growth, the test or-
ganisms were streaked perpendicularly. A space of 
2-3 mm was kept between two streaks. Then the 
plates were incubated at 37°C for the growth of the 
test organisms. The plates were then observed for 
organisms sensitive to the metabolites produced 
by the isolates. A clear zone of inhibition appeared 
against those organisms. 
Identification and optimization of culture 
conditions for isolates
The selected isolate MU 37 was identified on the 
basis of morphological, cultural and physiological 
behaviors. These characteristics were compared 
with standard description of Bergey’s Manual of 
Determinative Bacteriology.17 The organisms which 
showed a considerable inhibition to the test organ-
isms in primary screening were selected for mass 
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may produce an antimicrobial metabolite but it may 
not do so in liquid media. The production of an anti-
biotic may be influenced by different types of factors 
such as composition and pH of media, incubation 
period, temperature and condition (Shake or sta-
tionary). So the maximum yield of an antibiotic de-
pends on the optimization of these factors.
Antibiotic assay by agar cup plate method
In performing the sensitivity spectrum analyses by 
agar cup plate method, nutrient agar plates were 
heavily seeded uniformly (2.7 x 103 cells/ml) with 
the test organisms. Then a hole was made in me-
dia by gel cutter in sterile condition. Then one drop 
of melted agar was poured into hole and allowed 
to solidify to make a base layer. After that specific 
amount of culture filtrate (0.1 ml) was poured into 
the hole. Then plates were kept at low temperature 
(4°C) for 2-4 hours to allow maximum diffusion. The 
plates were then incubated at 37°C for 24 hours at 
inverted position to allow maximum growth of the or-
ganisms. The antibacterial activity of the test agent 
was determined by measuring the diameter of zone 
of inhibition expressed in millimeter.18 The experi-
ment was carried out more than once and mean of 
reading was recorded.
Establishment of suitable culture medium
Four different media were prepared for antibiotic 
production: Medium A: Beef extract (3 g), Pep-
tone (5 g), NaCl (5 g), Distilled Water (1000 ml); 
Medium B: Yeast extract (0.2%), Glucose (1.0%), 
K2HPO4 (0.1%), NaCl (0.5%); Medium C: Beef ex-
tract (0.75%), Peptone (0.25%), NaCl (1.5%), KCl 
(1.0%), MgCl2 (1.0%), FeSO4 (1.0%); Medium D: 
Corn steep liquor (0.2%), Glucose (1.0%), K2HPO4 
(0.1%), NaCl (0.5%). The pH of media was adjust-
ed at 7.0. 150 cc of the medium was taken in each 
500 cc conical flask. Each type of the medium was 
prepared in duplicate. Then the sterile media were 
inoculated with the specific organisms at 10% in-
oculums potential (15 cc) and incubated at 37°C. 
The product was assayed by agar cup method at an 
interval of three days and continued up to 6 days.
Optimization of incubation period, temperature, 
media pH, carbon sources and stationary and shak-
ing incubation condition
The effect of incubation periods on the antibi-
otic production by selected isolates was also stud-
ied. For this reason 50 ml of selected medium was 
taken in each 100 ml conical flask and autoclaved. 
After cooling the broth medium was inoculated with 
equal quantity of inoculums, incubated at 37°C for 
2, 4, 6 and 8 days. Then the culture filtrate was as-
sayed for antibiotic production. After inoculation, the 
culture medium with optimum pH was incubated at 
different temperatures such as 27°C, 30°C, 35°C, 
40°C, and 45°C for optimum incubation period. 
The culture filtrate was assayed for maximum an-
tibiotic production by agar cup plate method. To 
observe the effect of pH on antibiotic production, 
the selected medium was prepared at different pH 
(6.0, 7.0, 8.0, 9.0, 10.0 and 11.0), dispensed 50 ml 
per 100 ml conical flask and autoclaved. Then the 
medium was inoculated and incubated at 37°C for 
optimum days. After incubation the culture filtrate 
was assayed for antibiotic production. The produc-
tion of antibiotic using different carbon source was 
studied in the selected culture medium. Four carbon 
sources (glucose, fructose, sucrose, starch) were 
added  to  the  selected  medium  and  after  specific 
period of incubation the culture media were filtered 
and assayed for antibiotic production. To determine 
the effect of stationary and shaking conditions broth 
medium was inoculated and incubated in both sta-
tionary and shaking conditions keeping all other 
experimental conditions at optimum. After specific 
period the culture media were filtered and assayed 
for antibiotic production of antimicrobial metabolite. 
Production and recovery of antimicrobial 
metabolite
i) Fermentation: Selected media were pre-
pared, sterilized and then inoculated with 5-10% 
(v/v) of inoculums of selected strain MU 37. All opti-
mum conditions were maintained for maximum pro-
duction of antimicrobial metabolite.
ii) Isolation of antimicrobial agent: The isolation 
of the antibiotic from the culture broth was achieved 
by extraction with an organic solvent not complete-
ly miscible with water. In this case the solubility of 
the antibiotic in different organic solvent was first 
investigated in order to find out a suitable solvent. 
The solvents used were petroleum ether, n-butanol, 
chloroform and benzene. For solvent- solvent parti-
tioning of product the fermented product was gen-
tly shaken in a separating funnel with almost equal 
volume of pure petroleum ether, which is immiscible 
with aqueous alcohol. The mixture was then kept for 
several minutes for separating of the organic layer 
from the aqueous phase. The materials of the crude 
extract were partitioned between the two phases 
depending on their affinity towards their respective 
solvents. The organic layer was separated and col-
lected in a conical flask and the process was re-
peated thrice. After collection of organic phase, the 
aqueous phase thus obtained was further extracted 
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polarity like n-butanol, chloroform and benzene in 
the same way. Finally all the fractions were collect-
ed separately and dried in an oven (50°C). Finally 
gummy substances were collected and mixed with 
distilled water with concentration of 0.5 mg/ml. For 
the test of antimicrobial sensitivity of the extracts 
disc diffusion method was used and 50 µg of con-
centration was tested against pathogens and dis-
tilled water was used as a blank.
Studies for the antimicrobial metabolite stability 
at different pH and temperatures
Twenty-five ml of potent culture filtrate was taken in 
50 ml conical flask in duplicates and the pH of the 
filtrate was adjusted at pH 3, 5, 7, 9, 11 by adding 
buffer solution. Then the flasks were kept inside the 
refrigerator for two hours and then the antibiotic was 
solvent extracted and assayed by agar cup plate 
method.  Twenty-five  ml  of  potent  culture  filtrate 
was taken in a 50 ml conical flask in duplicates and 
heated in water bath at different temperature (60°C, 
70°C, 80°C, 90°C, 100°C and autoclave tempera-
ture 121°C) for half an hour. Then the antibiotic was 
extracted with the best solvent (chloroform) and as-
sayed by agar cup plate method.
RESULTS
Primarily, 15 soil samples were collected from differ-
ent chili fields in Chittagong, Bangladesh. Then the 
soil samples were examined by pour plating tech-
nique on three different media namely- nutrient agar 
medium, oat meal agar medium and starch casein 
medium  to  find  out  any  antagonistic  microorgan-
isms present. Following incubation, 14 antagonistic 
microorganisms (actinomycetes and bacteria) sur-
rounded by a zone of inhibition and the inhibited 
ones were isolated. These were purified and pre-
served and the inhibiting isolates were tested for 
their antimicrobial activity.
The previous sensitivity spectrum analysis 
tests on NA medium revealed that the antimicrobial 
agent produced by the isolate MU 37 was active 
strongly against B. subtilis, V. cholerae, E. coli, B. 
cereus, P. aeruginosa, S. dysenteriae, and weakly 
active against S. aureus, S. sonnei, B. megaterium 
and S. typhi and wide spectrum antimicrobial agent 
production by actinomycetes isolate was also re-
ported.19 On the basis of their better antimicrobial 
activity against 10 pathogenic test organisms in 
three different media, the actinomycetes isolate MU 
37 was finally selected for detailed study (Table 1). 
On the basis of their morphological, cultural and bio-
chemical characteristics, the actinomycetes isolate 
MU 37 was found to belong to the genus Streptomy-
ces. It was provisionally identified as Streptomyces 
albolongus.17
Optimization of culture conditions for maximum 
production of antimicrobial metabolite 
Among the four media used the medium D was 
found suitable for antimicrobial metabolite produc-
tion (Figure 1). Following medium selection other 
tests were done on it. S. albolongus exhibited a 
wide range of antimicrobial activity (zone of inhibi-
tion) against different test organisms. The highest 
activity was found against S. sonnei, B. subtilis and 
S. aureus after 6 days of incubation which is very 
close to a report describing the maximum of anti-
microbial activity at 5th day of incubation by Strep-
tomyces spp.20
Effect of incubation temperature and pH on 
antimicrobial metabolite production
The actinomycetes isolate S. albolongus exhibited 
maximum antimicrobial metabolite production at 
35°C (Table 2). It also showed maximum antimicro-
bial activity against S. aureus (zone of inhibition 33 
mm) at pH 9.0.
Effect of carbon sources on the production of 
antimicrobial metabolite
Among the four carbon sources sucrose has sig-
nificant effect on the production of antimicrobial me-
tabolite which results in maximum activity against B. 
subtilis (zone of inhibition 31.5 mm).
Effect of incubation condition (stationary/
shaking) on antimicrobial metabolite 
production
Shaking incubation condition was found optimum 
for the production of antimicrobial metabolite as 
compared to stationary culture (Figure 2). This re-
sult complies with the report which described better 
bioactive metabolite production at shaking condition 
by Streptomyces spp. 201.21
Antimicrobial sensitivity assay of extracted 
metabolites
The activity of different extracted fraction of the 
metabolites was tested by agar cup plate method. 
Chloroform was found best for the solvent extrac-
tion of the metabolites produce by S. albolongus.
Determination of pH and temperature stability 
of the antimicrobial metabolite
The activity of the antimicrobial metabolite was 
found to be stable up to pH 11.0 (Figure 3) and 
temperature at 100°C which corresponds to the re-
port on heat stable active component production by 
Streptomyces.20Uddin M, et al. Bioactive Metabolite Production by Streptomyces albolongus 79
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Table 1. Morphological, cultural, physiological and biochemical characteristics of the MU 37 actinomycetes isolate
Character Observations
Vegetative mycelium Filamentous, non-septated, branched
Spore Smooth chain
Gram staining Gram positive
Acid fast staining Non-acid fast
Colonies on starch casein agar Form: circular; Margin: erose; Elevation: umbonate, Surface: concentric;
Mycelium color: whitish; Spore color: grey; Diffusible pigment: light brown
Starch casein agar slant +++, filiform, gray sporulation, yellow diffusible colour
Nutrient agar slant ++, scanty white sporulation, yellow diffusible color
Nutrient broth Ring formation, low turbid and sediment present
Modified nutrient broth Pellicle, turbid, sediment present
Starch casein broth +++, Ring formation, turbid, sediment present
Catalase test Positive
Deep glucose agar test Heavy growth on surface, few colonies just below the surface
Casein hydrolysis Strongly positive
Starch hydrolysis Weakly positive
Egg albumin test Negative
Gelatin hydrolysis Positive 
Nitrate reduction test Positive 
Fermentation test
Acid (without gas): Glucose Glycerol
Strong alkali: Sucrose, Lactose, xylose, arabinose, Raffinose, Maltose, cellulose
Moderate alkali: Starch, galactose, rhamnose, inulin and week from fructose
No fermentation: Mannitol 
Figure 1. Production of active agents in different culture media by Streptomyces albolongusUddin M, et al. Bioactive Metabolite Production by Streptomyces albolongus 80
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Figure 2. Production of active agents at stationary and shaking condition by Streptomyces albolongus
Figure 3. Stability of the active metabolite produced by Streptomyces albolongus at different pH values. 
Table 2. Obtained inhibition zones against test microor-
ganisms by MU 37 isolate in different incubation tempera-
tures*
Test organisms 27°C 30°C 35°C 40°C 45°C
Staphylococcus aureus 26 25.5 30.5 23.5 -
Bacillus subtilis 25.5 26 29.5 24 -
Bacillus cereus 24.5 26 27.5 24 -
Shigella dysenteriae 26.5 29 31.5 29 -
Shigella sonnei 28 28 35 25.5 -
*Data presented as mm
DISCUSSION
Antibiotic production by microorganisms is greatly 
dependent on the selective environmental pressure 
prevailing at its source of isolation and manipulation 
of growth and nutritional conditions during fermenta-
tion exerts substantial influence on the level of me-
tabolite production.22 The composition and concen-
trations of the constituents of the media are closely 
linked with the metabolic capacities of the producing 
organism and greatly influence the biosynthesis of 
the bioactive molecules. Equally, the effect of other 
factors including medium volume, oxygen transfer 
rate, temperature, initial pH of the medium, and in-
cubation time on secondary metabolites production 
were frequently reported. These factors have great 
motivation on increase of metabolite production by 
different kinds of actinomycetes. All these param-
eters were considered during production of antimi-
crobial metabolites by MU 37 and during recovery 
by solvent chloroform optimized conditions were 
followed.
In our study, use of medium D (Figure 1) pro-
vides maximum antimicrobial metabolite production. 
Other parameters were also optimized. Sanchez 
and Demain14 have listed several carbon sources 
which interfere with the antibiotic production. Sugar 
can affect the metabolism directly by decreasing the Uddin M, et al. Bioactive Metabolite Production by Streptomyces albolongus 81
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time for switching over to stationary phase.23 We 
found during production 1% glucose concentration 
in medium D has greatly induces antibiotic produc-
tion. Abbanat et al.24 have found that glucose con-
centration  influence  metabolite  production.  More-
over, when medium D have supplemented with 1% 
sucrose (data not shown) production of metabolite 
has increased in a significant way.
The level of antibiotic production may be great-
ly influenced by the nature; type and concentration 
of the nitrogen source supplied in the culture medi-
um.25 Mohamed et al.26 showed that nitrogen source 
(inorganic and organic) exhibited a significant effect 
on the natamycin production. Our results are in 
agreement with the results of the study. The medi-
um D used for metabolites production contains corn 
steep liquor which is a good source for all amino 
acids, and nitrogen compounds. The mineral K2H-
PO4 (in medium D) also have good contribution on 
bioactive metabolite production by the investigated 
strain MU 37. Other environmental factors like pH, 
incubation temperature, incubation period, and air 
relation were also found to have profound influence 
on antibiotic production.27 The maximum antibiotic 
activity was obtained at a pH of 9.0 suggesting its 
inclusion in the alkaliphilic actinomycetes group. 
This is in agreement with the results obtained by 
Sanjay et al.28 They found for good antibiotic pro-
duction by S. griseus at a pH value of 9.0 was suit-
able. The influence of temperature on the bioactive 
metabolite production of the strain is presented in 
Table 2. Highest growth, as well as antimicrobial 
compound production, was obtained at 35°C. In 
terms of its optimum temperature for growth, the or-
ganism appeared to be mesophilic. These results 
are in complete accordance with those reported by 
Narayana and Vijayalakshmi.29
In this study, the stability of antibiotics at dif-
ferent temperatures and pH values were examined. 
The metabolites from isolate MU 37 were stable at 
temperature ranges from 60 to 100°C however un-
stable after autoclaving. Stability was also examined 
at different pH varies from 5 to 11. Maximum activity 
was found at pH 7 and activity was decreased with 
increase or decrease of pH value. Mustafa et al.30 
also reported about study of antimicrobial activity of 
antibiotic metabolites on subjection to different tem-
peratures and pH levels. Using all optimum condi-
tions metabolites were trying to recover from broth 
culture using different solvents like n-butanol, petro-
leum ether, chloroform and benzene. Among them, 
chloroform (Table 3) was found best for recovery of 
the metabolites.
Table 3. Obtained 
inhibition zones 
by different ex-
tracted fractions 
(1) against test 
microorganisms*
Test microorganisms n-butanol Petroleum ether Chloroform Benzene Control
Staphylococcus aureus 21 42 27 0
Bacillus subtilis 22.2 - 42.5 28.5 0
Bacillus cereus 22 11.5 42 29 0
*Data presented as mm
In conclusion, it is clear that based on mor-
phological, cultural, physiological and biochemical 
characteristics the new Actinomycetes MU 37 has 
been assigned as S. albolongus. Optimal conditions 
for the production of bioactive metabolites and re-
covery using solvent were determined, and metabo-
lites showed good antimicrobial activity against both 
Gram positive and Gram negative bacteria. Further 
studies  on  their  purification,  characterization  and 
identification of bioactive metabolites are in prog-
ress.
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